CSIMarket Company Name, Ticker, Industry, else..
 
Standard Biotools Inc   (NASDAQ: LAB)
Other Ticker:  
 
 

Standard Biotools Inc Income Statement Quarterly

LAB


Download as CSV


Select the Financial Report:   Period:

New: More LAB's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Sep 30 2025)
Q3 2025		 (Jun 30 2025)
Q2 2025		 (Mar 31 2025)
Q1 2025		 (Dec 31 2024)
Q4 2024		 (Sep 30 2024)
Q3 2024
Revenue From Contract With Customer Excluding Assessed Tax 19.55 21.76 40.80 44.97
Interest Income, Operating 2.14 2.46 2.92 3.94
License And Collaboration Revenue - - - -
Other Revenue -2.21 -2.60 -2.97 -4.65
Total Revenue 19.48 21.63 40.74 47.91 44.26
Cost of Goods and Services Sold 10.00 11.00 21.00 26.00 21.00
Gross Profit 9.48 10.63 19.74 21.91 23.26
Selling, Administration, Marketing 26.60 28.11 38.71 37.59 34.40
Depriciation & Amortization - - - - -
Research and Development Expense 6.36 6.22 11.33 14.05 13.16
Restructuring, Accretion & impairment charges 9.47 2.00 2.68 3.08 7.42
Other operatinig exp. /-income 0.00 0.00 - - -
Unusual Expense /-Income - - - - -
Total operating costs including COS 52.42 47.33 73.71 80.72 75.98
Operating income/-loss -32.94 -25.70 -32.97 -32.82 -31.72
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Loss/ -Gain on Investment - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Business Combination, Bargain Purchase, Gain Recognized, Amount - - - - -
Other loss/ -income -0.04 -7.42 -6.79 0.98 -4.90
Total costs & expenses 52.38 39.91 66.93 81.71 71.08
Income /-loss before income taxes -32.90 -18.28 -26.18 -33.80 -26.82
Income taxes expenses/-benefit -1.22 -0.61 -0.15 0.27 0.12
Income after income taxes -31.68 -17.67 -26.03 -34.07 -26.94
Net income/-loss of other equity - - - 0.00 -
Income/-loss from cont. Ops. -31.68 -17.67 -26.03 -34.07 -26.94
Accounting change - - - - -
Discontinued operations -3.00 -15.79 - - -
Extraordinary items - - - - -
Net Income/-loss -34.69 -33.46 -26.03 -34.07 -26.94
Non-controlling interests - - - - -
Preferred dividends - - - - -
Other - - - - -
Income/-loss to shareholder -34.69 -33.46 -26.03 -34.07 -26.94
EBIT -32.90 -18.28 -26.18 -33.80 -26.82
EBITD -31.38 -15.11 -22.91 -30.66 -23.67
EBITDA -31.38 -14.29 -22.01 -29.85 -22.96


Per Share (GAAP Quarterly, in $) (Sep 30 2025)
Q3 2025		 (Jun 30 2025)
Q2 2025		 (Mar 31 2025)
Q1 2025		 (Dec 31 2024)
Q4 2024		 (Sep 30 2024)
Q3 2024
Basic EPS (excl. extra items) -0.08 -0.05 -0.07 -0.09 -0.07
   Extraordinary items -0.01 -0.04 0.00 0.00 0.00
Basic Net EPS -0.09 -0.09 -0.07 -0.09 -0.07
Basic shares outstanding (Mill. of Units) 382.63 380.50 378.23 374.99 371.54
   EPS other shares - - - - -
Diluted Net EPS -0.09 -0.09 -0.07 -0.05 -0.07
Diluted average shares (Mill. of Units) 382.63 380.50 378.23 355.58 371.54
Dividend per share - - - - -


Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.